Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Atopic Dermatitis (AD)”

Showing 16 of 0 results

Large-scale testing (Phase 3)Study completedNCT02755649
What this trial is testing

Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically Advisable

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 325
Testing effectiveness (Phase 2)Study completedNCT00914186
What this trial is testing

Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC)

Who this might be right for
Atopic Dermatitis
Taisho Pharmaceutical R&D Inc. 122
Testing effectiveness (Phase 2)Ended earlyNCT03517566
What this trial is testing

Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 293
Early research (Phase 1)Ended earlyNCT05859724
What this trial is testing

Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Yellow Jersey Therapeutics AG 126
Early research (Phase 1)Looking for participantsNCT07239947
What this trial is testing

BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Bambusa Therapeutics 99
Not applicableUnknownNCT04087863
What this trial is testing

Administration for Placebo Group and Evalution the Safety and Efficacy in Atopic Dermatitis Patients

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 99
Testing effectiveness (Phase 2)Study completedNCT07712536
What this trial is testing

Phase IIa Study of Pharmacokinetics, Safety and Efficacy of QY201 Tablets in Adolescent Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Adolescent Participants With Moderate to Severe Atopic Dermatitis (AD)
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. 24
Not applicableStudy completedNCT05394792
What this trial is testing

An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing Dupilumab

Who this might be right for
Atopic Dermatitis
AbbVie 111
Post-approval studies (Phase 4)Study completedNCT00673725
What this trial is testing

Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Astellas Pharma Europe B.V. 49
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07782476
What this trial is testing

Study of HXN6005 in Healthy Participants and Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Health Adult SubjectsAtopic Dermatitis (AD)
Helixon Biotechnology (Suzhou) Co., Ltd 67
Large-scale testing (Phase 3)Study completedNCT03526861
What this trial is testing

Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).

Who this might be right for
Atopic Dermatitis
LEO Pharma 301
Not applicableTemporarily pausedNCT04031469
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Who this might be right for
Gut MicrobiomeGastrointestinal MicrobiomeAutism+77 more
ProgenaBiome 1,000
Testing effectiveness (Phase 2)Study completedNCT05131477
What this trial is testing

Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study

Who this might be right for
EczemaAtopic Dermatitis
Kymab Limited 390
Testing effectiveness (Phase 2)Study completedNCT03921411
What this trial is testing

A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Galderma R&D 20
Early research (Phase 1)Study completedNCT02647086
What this trial is testing

Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 14
Large-scale testing (Phase 3)Study completedNCT05651711
What this trial is testing

A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)

Who this might be right for
Atopic Dermatitis
Amgen 726

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation